Green Sky Labs

Green Sky Labs is a biotechnology incubator and intellectual property developer specializing in the cannabinoid and psychedelic medicine spaces. The company focuses on creating advanced delivery systems, such as water-soluble nano-emulsions, and proprietary extraction technologies to improve the bioavailability and consistency of botanical compounds. Green Sky Labs operates by identifying high-potential scientific research and spinning it off into dedicated commercial entities, most notably Mynd Life Sciences. Their portfolio includes a range of pharmaceutical-grade formulations aimed at treating inflammatory and neurological conditions. The firm provides a bridge between academic discovery and commercial-scale manufacturing and clinical trials. By leveraging a network of scientific experts and strategic partnerships, Green Sky Labs aims to bridge the gap between raw botanical materials and standardized medical treatments.